Semester:
Fall
Topics in Medical Device Comparative Effectiveness Research (EPI521) is offered in Fall 2 every other year on even numbers years.
Joshua Gagne
Associate Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Department of Epidemiology, Harvard T.H. Chan School of Public Health
Contact
Recent Publications
- Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars
- Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches
- Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover Study
-
@RachBarenie 31 points for Kombiglyze plus another 9 for XR. That’s currently 2nd place for one word names and 2nd place overall counting the XR.
-
@anecdatally 34 points!! That tops Xeljanz and Zyprexa for one-word names.
-
I have another fun (and perhaps more original) drug name games that I'll roll out next week. Stay tuned.